Latest News- Interventional Oncology Market: Hospitals and diagnostic centers is expected to lead the End-user segment during 2025-2029

The Interventional Oncology Market is being driven by Increase prevalence of cancer

The Interventional Oncology Market is expected to grow at a CAGR of 9% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 1663.4 million. The Interventional Oncology market is witnessing significant growth due to the increasing adoption of Microwave Ablation (MWA) technology. MWA offers numerous advantages over conventional procedures, including a flexible treatment approach for various cancers, such as Hepatocellular Carcinoma (HCC). Key drivers fueling this adoption include minimized procedure time of 5-10 minutes, enhanced efficacy with decreased complications, and shorter hospital stays. Notably, the demand for MWA devices is anticipated to be particularly high for liver and lung cancer treatments, given the pressing need for effective therapeutic solutions. Companies like MedWaves Inc. are at the forefront of innovation, developing advanced MWA devices to cater to the burgeoning market demand. 

Get more information on Interventional Oncology Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• End-user
  • Hospitals and diagnostic centers
  • Ambulatory surgery centers
  • Research and academic institutes
• Product
  • Particle embolization
  • Ablation
  • Support devices
• Disease Type
  • Liver cancer
  • Lung cancer
  • Kidney cancer
  • Bone metastases
  • Others
• Geography
  • North America
    • Canada
    • Mexico
    • US
  • Europe
    • Germany
    • UK
    • France
  • Asia
    • China
    • India
    • Japan
    • South Korea
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Increase prevalence of cancer
• Growing demand for minimally invasive surgical procedures
• Growing focus on research and development activities in interventional oncology

However, the market also witnesses some limitations, which are as follows:

• High cost of interventional oncology procedures
• Presence of alternatives to interventional oncology solutions
• Risks associated with interventional oncology procedures

Benefits of Buying Global Interventional Oncology Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Interventional Oncology Market Research Report

Request Free Sample

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

Interventional Oncology Market involves advanced technologies such as procedural navigation, 3D imaging, and robotic surgery, utilizing surgical robots and image-guided navigation for precise tumor targeting and localization. Real-time imaging aids in tissue ablation and embolization agents, while drug eluting stents and transarterial chemoembolization impact tumor vascularization. AI, machine learning, and big data analysis contribute to clinical decision support, patient education, and personalized treatment plans, addressing tumor growth, response, shrinkage, recurrence, neoadjuvant therapy, adjuvant therapy, palliative care, clinical pathways, and patient support.

Market Research Overview

The Interventional Oncology market, a segment of the larger Life Science Tools and Services market, is experiencing significant growth due to the increasing prevalence of cancer and the subsequent demand for minimally invasive procedures such as image-guided surgery and tumor ablation techniques like radiofrequency ablation. These advanced procedures, which include technologies like CT, MRI, and ultrasound imaging, enable precise and targeted treatment of cancerous tumors with minimal damage to surrounding healthy tissue. Additionally, the market's expansion is driven by an aging population, as the global population over 60 years is predicted to increase significantly, leading to a higher incidence of cancer cases. Overall, the Interventional Oncology market is poised for robust growth, fueled by advancements in technology and the rising demand for less invasive cancer treatment options.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/